Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

February 1, 2016; Volume 57,Issue 2

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 8A;

SNMMI Newsline

  • You have access
    NIH Releases Strategic Plan; Secures Enhanced Funding
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 9N;
  • You have access
    2015 Kocemba–Slosky Fellowship
    Phillip Koo
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 10N;
  • You have access
    In Memoriam: Alan Davison, PhD, 1936–2015
    James Kronauge and Alan B. Packard
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 11N-15N;
  • You have access
    Looking to the Future: The ABNM in the Next 10 Years
    George M. Segall
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 12N;
  • You have access
    SNMMI Leadership Update: Clinical Trials Network Update
    Virginia Pappas
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 13N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 14N-15N;
  • You have access
    From The Literature
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 16N-20N;

Focus on Molecular Imaging

  • You have access
    Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases?
    Lucy Vivash and Terence J. O’Brien
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 165-168; DOI: https://doi.org/10.2967/jnumed.114.141713

Invited Perspectives

  • You have access
    uPAR as a Glioma Imaging Target
    Kenji Hirata and Nagara Tamaki
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 169-170; DOI: https://doi.org/10.2967/jnumed.115.166231
  • You have access
    Harnessing the Power of Molecular Imaging for Precision Medicine
    Emily B. Ehlerding and Weibo Cai
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 171-172; DOI: https://doi.org/10.2967/jnumed.115.166199

Clinical Investigations

  • You have access
    DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy
    Uta Eberlein, Harry Scherthan, Christina Bluemel, Michel Peper, Constantin Lapa, Andreas Konrad Buck, Matthias Port and Michael Lassmann
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 173-179; DOI: https://doi.org/10.2967/jnumed.115.164814
  • You have access
    Significance of a Single-Time-Point Somatostatin Receptor SPECT/Multiphase CT Protocol in the Diagnostic Work-up of Gastroenteropancreatic Neuroendocrine Neoplasms
    Juri Ruf, Friederike von Wedel, Christian Furth, Timm Denecke, Lars Stelter, Ingo G. Steffen, Kerstin Schütte, Jörg Arend, Gerhard Ulrich, Silke Klose, Jan Bornschein, Ivalya Apostolova and Holger Amthauer
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 180-185; DOI: https://doi.org/10.2967/jnumed.115.161117
  • You have access
    68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI
    Ingo Janssen, Clara C. Chen, David Taieb, Nicholas J. Patronas, Corina M. Millo, Karen T. Adams, Joan Nambuba, Peter Herscovitch, Samira M. Sadowski, Antonio T. Fojo, Inga Buchmann, Electron Kebebew and Karel Pacak
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 186-191; DOI: https://doi.org/10.2967/jnumed.115.161018
  • You have access
    Imaging Angiogenesis Using 99mTc-Macroaggregated Albumin Scintigraphy in Patients with Peripheral Artery Disease
    Gen Takagi, Masaaki Miyamoto, Yoshimitsu Fukushima, Masahiro Yasutake, Shuhei Tara, Ikuyo Takagi, Naoki Seki, Shinichiro Kumita and Wataru Shimizu
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 192-197; DOI: https://doi.org/10.2967/jnumed.115.160937
  • You have access
    Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans
    Michael Rullmann, Juergen Dukart, Karl-Titus Hoffmann, Julia Luthardt, Solveig Tiepolt, Marianne Patt, Hermann-Josef Gertz, Matthias L. Schroeter, John Seibyl, Walter J. Schulz-Schaeffer, Osama Sabri and Henryk Barthel
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 198-203; DOI: https://doi.org/10.2967/jnumed.115.161893
  • You have access
    Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment
    Timo Grimmer, Carolin Wutz, Panagiotis Alexopoulos, Alexander Drzezga, Stefan Förster, Hans Förstl, Oliver Goldhardt, Marion Ortner, Christian Sorg and Alexander Kurz
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 204-207; DOI: https://doi.org/10.2967/jnumed.115.163717
  • You have access
    18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
    Ryuichi Harada, Nobuyuki Okamura, Shozo Furumoto, Katsutoshi Furukawa, Aiko Ishiki, Naoki Tomita, Tetsuro Tago, Kotaro Hiraoka, Shoichi Watanuki, Miho Shidahara, Masayasu Miyake, Yoichi Ishikawa, Rin Matsuda, Akie Inami, Takeo Yoshikawa, Yoshihito Funaki, Ren Iwata, Manabu Tashiro, Kazuhiko Yanai, Hiroyuki Arai and Yukitsuka Kudo
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 208-214; DOI: https://doi.org/10.2967/jnumed.115.164848
  • You have access
    Evaluation of Atlas-Based Attenuation Correction for Integrated PET/MR in Human Brain: Application of a Head Atlas and Comparison to True CT-Based Attenuation Correction
    Tetsuro Sekine, Alfred Buck, Gaspar Delso, Edwin E.G.W. ter Voert, Martin Huellner, Patrick Veit-Haibach and Geoffrey Warnock
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 215-220; DOI: https://doi.org/10.2967/jnumed.115.159228
  • You have access
    Age-Related Sex-Specific Changes in Brain Metabolism and Morphology
    Akihiro Kakimoto, Shigeru Ito, Hiroyuki Okada, Sadahiko Nishizawa, Satoshi Minoshima and Yasuomi Ouchi
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 221-225; DOI: https://doi.org/10.2967/jnumed.115.166439
  • You have access
    Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size
    Brenda F. Kurland, Mark Muzi, Lanell M. Peterson, Robert K. Doot, Kristen A. Wangerin, David A. Mankoff, Hannah M. Linden and Paul E. Kinahan
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 226-230; DOI: https://doi.org/10.2967/jnumed.115.162289
  • You have access
    Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study
    Shakeel Modak, Pat Zanzonico, Jorge A. Carrasquillo, Brian H. Kushner, Kim Kramer, Nai-Kong V. Cheung, Steven M. Larson and Neeta Pandit-Taskar
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 231-237; DOI: https://doi.org/10.2967/jnumed.115.161752
  • You have access
    Diagnostic Reference Levels of CT Radiation Dose in Whole-Body PET/CT
    Ngoneh Jallow, Paul Christian, John Sunderland, Michael Graham, John M. Hoffman and Jonathon A. Nye
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 238-241; DOI: https://doi.org/10.2967/jnumed.115.160465
  • You have access
    The PET Radioligand 18F-FIMX Images and Quantifies Metabotropic Glutamate Receptor 1 in Proportion to the Regional Density of Its Gene Transcript in Human Brain
    Paolo Zanotti-Fregonara, Rong Xu, Sami S. Zoghbi, Jeih-San Liow, Masahiro Fujita, Mattia Veronese, Robert L. Gladding, Denise Rallis-Frutos, Jinsoo Hong, Victor W. Pike and Robert B. Innis
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 242-247; DOI: https://doi.org/10.2967/jnumed.115.162461

Brief Communications

  • You have access
    First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease
    Ken Herrmann, Margret Schottelius, Constantin Lapa, Theresa Osl, Andreas Poschenrieder, Heribert Hänscheid, Katharina Lückerath, Martin Schreder, Christina Bluemel, Markus Knott, Ulrich Keller, Andreas Schirbel, Samuel Samnick, Michael Lassmann, Saskia Kropf, Andreas K. Buck, Hermann Einsele, Hans-Juergen Wester and Stefan Knop
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 248-251; DOI: https://doi.org/10.2967/jnumed.115.167361

Continuing Education

  • You have access
    Gastrointestinal Bleeding Scintigraphy in the Early 21st Century
    Erin Grady
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 252-259; DOI: https://doi.org/10.2967/jnumed.115.157289

Basic Science Investigations

  • You have access
    Comparison of the Therapeutic Response to Treatment with a 177Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models
    Simone U. Dalm, Julie Nonnekens, Gabriela N. Doeswijk, Erik de Blois, Dik C. van Gent, Mark W. Konijnenberg and Marion de Jong
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 260-265; DOI: https://doi.org/10.2967/jnumed.115.167007
  • You have access
    Mapping Radiation Injury and Recovery in Bone Marrow Using 18F-FLT PET/CT and USPIO MRI in a Rat Model
    David A. Rendon, Khushali Kotedia, Solmaz F. Afshar, Jyotinder N. Punia, Omaima M. Sabek, Beverly A. Shirkey, Janice A. Zawaski and M. Waleed Gaber
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 266-271; DOI: https://doi.org/10.2967/jnumed.115.158121
  • You have access
    Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma
    Morten Persson, Mette K. Nedergaard, Malene Brandt-Larsen, Dorthe Skovgaard, Jesper T. Jørgensen, Signe R. Michaelsen, Jacob Madsen, Ulrik Lassen, Hans S. Poulsen and Andreas Kjaer
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 272-278; DOI: https://doi.org/10.2967/jnumed.115.161703
  • You have access
    Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma
    Shih-Hsun Cheng, Dou Yu, Hsiu-Ming Tsai, Ramin A. Morshed, Deepak Kanojia, Leu-Wei Lo, Lara Leoni, Yureve Govind, Lingjiao Zhang, Karen S. Aboody, Maciej S. Lesniak, Chin-Tu Chen and Irina V. Balyasnikova
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 279-284; DOI: https://doi.org/10.2967/jnumed.115.163006
  • You have access
    PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab
    Haiming Luo, Christopher G. England, Stephen A. Graves, Haiyan Sun, Glenn Liu, Robert J. Nickles and Weibo Cai
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 285-290; DOI: https://doi.org/10.2967/jnumed.115.166462
  • You have access
    Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer’s Disease Model Mice
    Miho Shukuri, Aya Mawatari, Masahiro Ohno, Masaaki Suzuki, Hisashi Doi, Yasuyoshi Watanabe and Hirotaka Onoe
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 291-296; DOI: https://doi.org/10.2967/jnumed.115.166116
  • You have access
    Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology
    Ian R. Macdonald, G. Andrew Reid, Ian R. Pottie, Earl Martin and Sultan Darvesh
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 297-302; DOI: https://doi.org/10.2967/jnumed.115.162032
  • You have access
    Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys
    Masakatsu Kanazawa, Hiroyuki Ohba, Norihiro Harada, Takeharu Kakiuchi, Shin-ichi Muramatsu and Hideo Tsukada
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 303-308; DOI: https://doi.org/10.2967/jnumed.115.161802
  • You have access
    Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide
    Géraldine Pottier, Solène Marie, Sébastien Goutal, Sylvain Auvity, Marie-Anne Peyronneau, Simon Stute, Raphaël Boisgard, Frédéric Dollé, Irène Buvat, Fabien Caillé and Nicolas Tournier
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 309-314; DOI: https://doi.org/10.2967/jnumed.115.164350
  • You have access
    In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl
    Sangram Nag, Patrik Fazio, Lutz Lehmann, Georg Kettschau, Tobias Heinrich, Andrea Thiele, Marie Svedberg, Nahid Amini, Samira Leesch, Ana M. Catafau, Jonas Hannestad, Andrea Varrone and Christer Halldin
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 315-320; DOI: https://doi.org/10.2967/jnumed.115.161083
  • You have access
    Molecular Imaging of Post-Src Inhibition Tumor Signatures for Guiding Dasatinib Combination Therapy
    Liquan Gao, Hao Liu, Xianlei Sun, Duo Gao, Chenran Zhang, Bing Jia, Zhaohui Zhu, Fan Wang and Zhaofei Liu
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 321-326; DOI: https://doi.org/10.2967/jnumed.115.158881

Book Reviews

  • You have access
    Perfusion Imaging in Clinical Practice: A Multimodality Approach to Tissue Perfusion Analysis
    Sundeep M. Nayak
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 327; DOI: https://doi.org/10.2967/jnumed.115.171025
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 57 (2)
Journal of Nuclear Medicine
Vol. 57, Issue 2
February 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases?
  • DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy
  • 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
  • Diagnostic Reference Levels of CT Radiation Dose in Whole-Body PET/CT
Sign up for alerts

Jump to

  • This Month in JNM
  • SNMMI Newsline
  • Focus on Molecular Imaging
  • Invited Perspectives
  • Clinical Investigations
  • Brief Communications
  • Continuing Education
  • Basic Science Investigations
  • Book Reviews
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire